Tirzepatide represents a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://flynnmxvh068843.popup-blog.com/39335709/tirzepatide-a-new-frontier-in-diabetes-treatment